Senior insider sale
GENERAL COUNSEL & CORP SEC at STOKE THERAPEUTICS, INC. — senior position signals high conviction
$955.7K
28.94K shares
What this filing means
ALLAN JONATHAN plans to sell 28.94K shares of STOKE THERAPEUTICS, INC. valued at approximately $955.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/16/2026ACC: 0001950047-26-006194
Officer· GENERAL COUNSEL & CORP SEC
Since Feb 2026
28.94K
Shares to sell
$955.7K
Approx. market value
1.46K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
3/15/2026
1.46KTotal acquired1.46K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/15/2026 | Restricted Stock Units N/A | 1.46K | — |
| Total | 1.46K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
9.29K
Market value
$313.0K
3/20/2026
—Completed
Units to sell
9.29K
Market value
$313.0K
3/20/2026
—Completed
Units to sell
4.63K
Market value
$145.1K
3/18/2026
—Completed
Units to sell
4.27K
Market value
$140.8K
3/17/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.46K
Market value
$43.7K
6/16/2026
Total
Units
28.94K
Value
$955.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/20/2026 | 9.29K | $313.0K | — | Completed |
3/20/2026 | 9.29K | $313.0K | — | Completed |
3/18/2026 | 4.63K | $145.1K | — | Completed |
3/17/2026 | 4.27K | $140.8K | — | Completed |
| Planned — Approximate Date | ||||
6/16/2026 | 1.46K | $43.7K | NASDAQ | Planned |
| Total | 28.94K | $955.7K | ||